NO974512D0 - Fremgangsmåte for syntese av nukleosid-analoger - Google Patents

Fremgangsmåte for syntese av nukleosid-analoger

Info

Publication number
NO974512D0
NO974512D0 NO974512A NO974512A NO974512D0 NO 974512 D0 NO974512 D0 NO 974512D0 NO 974512 A NO974512 A NO 974512A NO 974512 A NO974512 A NO 974512A NO 974512 D0 NO974512 D0 NO 974512D0
Authority
NO
Norway
Prior art keywords
synthesis
nucleoside analogs
intermediates
ethoxy
nucleoside
Prior art date
Application number
NO974512A
Other languages
English (en)
Other versions
NO316174B1 (no
NO974512L (no
Inventor
Vicente Samano
Mirna C Samano
Michael David Goodyear
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10772237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO974512(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO974512D0 publication Critical patent/NO974512D0/no
Publication of NO974512L publication Critical patent/NO974512L/no
Publication of NO316174B1 publication Critical patent/NO316174B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NO19974512A 1995-03-31 1997-09-29 Fremgangsmåte for syntese av nukleosid-analoger og mellomprodukter NO316174B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9506644.5A GB9506644D0 (en) 1995-03-31 1995-03-31 Preparation of nucleoside analogues
PCT/EP1996/001353 WO1996030369A1 (en) 1995-03-31 1996-03-26 Process for the synthesis of nucleoside analogues

Publications (3)

Publication Number Publication Date
NO974512D0 true NO974512D0 (no) 1997-09-29
NO974512L NO974512L (no) 1997-09-29
NO316174B1 NO316174B1 (no) 2003-12-22

Family

ID=10772237

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974512A NO316174B1 (no) 1995-03-31 1997-09-29 Fremgangsmåte for syntese av nukleosid-analoger og mellomprodukter

Country Status (17)

Country Link
US (2) US6143748A (no)
EP (1) EP0817784B1 (no)
JP (1) JP4173195B2 (no)
CN (2) CN1290845C (no)
AT (1) ATE241619T1 (no)
AU (1) AU5497396A (no)
BR (2) BR9607850B1 (no)
DE (1) DE69628424T2 (no)
DK (1) DK0817784T3 (no)
ES (1) ES2200060T3 (no)
GB (1) GB9506644D0 (no)
HK (1) HK1009451A1 (no)
HU (1) HU223100B1 (no)
NO (1) NO316174B1 (no)
PL (1) PL188693B1 (no)
PT (1) PT817784E (no)
WO (1) WO1996030369A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues
EP1104415B1 (en) 1998-08-12 2004-11-10 Gilead Sciences, Inc. Method of manufacture of 1,3-oxathiolane nucleosides
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
CN110156699A (zh) * 2019-05-22 2019-08-23 南京合巨药业有限公司 一种4-乙氧基-1h-嘧啶-2-酮的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9116601D0 (en) * 1991-08-01 1991-09-18 Iaf Biochem Int 1,3-oxathiolane nucleoside analogues
JP3499896B2 (ja) * 1993-03-12 2004-02-23 財団法人野口研究所 ２’−デオキシヌクレオシド類の製造方法
IL113432A (en) * 1994-04-23 2000-11-21 Glaxo Group Ltd Process for the diastereoselective synthesis of nucleoside analogues
GB9506644D0 (en) * 1995-03-31 1995-05-24 Wellcome Found Preparation of nucleoside analogues

Also Published As

Publication number Publication date
HUP9801576A3 (en) 2000-07-28
WO1996030369A1 (en) 1996-10-03
JP4173195B2 (ja) 2008-10-29
GB9506644D0 (en) 1995-05-24
ES2200060T3 (es) 2004-03-01
DE69628424D1 (de) 2003-07-03
AU5497396A (en) 1996-10-16
PT817784E (pt) 2003-10-31
DK0817784T3 (da) 2003-09-08
DE69628424T2 (de) 2004-03-18
BR9607850B1 (pt) 2010-11-30
CN1995022B (zh) 2013-01-02
PL322503A1 (en) 1998-02-02
PL188693B1 (pl) 2005-03-31
NO316174B1 (no) 2003-12-22
EP0817784B1 (en) 2003-05-28
ATE241619T1 (de) 2003-06-15
HU223100B1 (hu) 2004-03-29
US6143748A (en) 2000-11-07
US6066733A (en) 2000-05-23
CN1995022A (zh) 2007-07-11
HK1009451A1 (en) 1999-09-10
JPH11502826A (ja) 1999-03-09
EP0817784A1 (en) 1998-01-14
CN1290845C (zh) 2006-12-20
HUP9801576A2 (hu) 1999-05-28
NO974512L (no) 1997-09-29
BR9607850A (pt) 1998-07-14
BRPI9607850B8 (pt) 2019-11-05
CN1180356A (zh) 1998-04-29

Similar Documents

Publication Publication Date Title
DK0465297T3 (da) 9-Purinylphosphonsyre-derivater
KR950700298A (ko) 뉴클레오시드 치료제(Therapeutic Nucleosides)
IL101931A0 (en) Processes for the diastereoselective synthesis of nucleosides,and hydrofuran derivatives for use therein
ATE140923T1 (de) Verfahren zur herstellung von n4-acyl-5'-desoxy-5-fluorocytidinderivate
ES2149157T3 (es) Nuevo procedimiento para la preparacion de nucleotidos.
DK0653436T3 (da) 5-methyluridin-fremgangsmåde til fremstilling i stor målestok af 2',3'-didehydro-3'-deoxythymidin (d4T)
EP0021231A3 (en) Process for the preparation of 5'-deoxy-5-fluoro uridine and intermediates in this process as well as their application
ES2132419T3 (es) Nuevos agentes de nucleosidos 9-n-biciclicos utiles como inhibidores selectivos de citocinas proinflamatorias.
NO974512D0 (no) Fremgangsmåte for syntese av nukleosid-analoger
ATE304541T1 (de) Verfahren zur herstellung von purinderivaten und dessen zwischenprodukte
DE69612024D1 (de) Verfahren zur Herstellung von 1-(2'-Desoxy-2',2'-difluoro-d-ribo-pentofuranosyl)-cytosin aus 2-Desoxy-2,2-difluoro-beta-d-ribo-pentopyranose
SI1140933T1 (en) Process for preparing n6-substituted deaza-adenosine derivatives
FR2701027B1 (fr) Procede de synthese ameliore du 9-(beta-d-arabinofuranosyl)adenine 5'-phosphate.
FI960286A (fi) Välituotteita nukleosidien diastereoselektiivisiin synteesimenetelmiin

Legal Events

Date Code Title Description
MK1K Patent expired